Arlington, MA, United States of America

Chris Dockendorff

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Arlington, MA (US) (2016 - 2018)
  • Milwaukee, WI (US) (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Chris Dockendorff

Introduction

Chris Dockendorff is an accomplished inventor based in Arlington, MA (US). He holds a total of four patents that contribute significantly to the field of medical treatments. His work primarily focuses on developing compounds that target specific proteins involved in various diseases.

Latest Patents

One of his latest patents is titled "Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase." This invention provides compounds that inhibit protein disulfide isomerase (PDI), which can be used to treat or prevent diseases that benefit from PDI inhibition. Another notable patent is "Thiazole-based inhibitors of scavenger receptor BI." This application describes compounds and methods that inhibit Scavenger receptor class B, type I (SR-BI) activity, which can be utilized to mediate high-density lipoprotein (HDL) lipid uptake and treat hepatitis C viral infections.

Career Highlights

Chris Dockendorff has worked with prestigious organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to contribute to groundbreaking research and innovations in the medical field.

Collaborations

Throughout his career, Dockendorff has collaborated with notable colleagues, including Partha Pratim Nag and Sivaraman Dandapani. These collaborations have further enhanced his research and development efforts.

Conclusion

Chris Dockendorff's contributions to the field of medical inventions are noteworthy. His innovative patents and collaborations with esteemed institutions and colleagues highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…